FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks
Pharmacy Times
AUGUST 7, 2025
SHOW MORE The FDA intends to update opioid labels to highlight risks of addiction, overdose, and interactions, enhancing safety in pain management practices. 3 The guideline presents 12 voluntary, evidence-based suggestions for opioid management. 3,4 For pharmacists, these guideline and rule changes solidify a critical clinical role.
Let's personalize your content